Zhengye Biotechnology Holding (ZYBT) Accounts Payables (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Accounts Payables of $6.2 million for Q4 2025, up 3.75% year-over-year from $6.0 million in Q4 2024, and up 3.85% quarter-over-quarter from $6.0 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Accounts Payables (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Accounts Payables for 3 consecutive years, with $6.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accounts Payables rose 3.75% year-over-year to $6.2 million; the TTM figure through Dec 2025 stood at $6.2 million (up 3.75% YoY), while the FY2025 annual figure was $6.3 million, up 6.98% from the prior year.
- Accounts Payables advanced to $6.2 million in Q4 2025 per ZYBT's latest filing, from $6.0 million in the prior quarter.
- Across five years, Accounts Payables topped out at $6.3 million in Q4 2023 and bottomed at $6.0 million in Q2 2025.
- Historically, Accounts Payables has averaged $6.1 million across 3 years, with a median of $6.1 million in 2024.
- Annual changes were most pronounced in 2024 — Accounts Payables declined 5.69% — and 2025, when it rose 3.75%.
- Zhengye Biotechnology Holding's Accounts Payables stood at $6.3 million in 2023, then retreated by 5.69% to $6.0 million in 2024, then rose by 3.75% to $6.2 million in 2025.
- Business Quant data shows ZYBT's Accounts Payables at $6.2 million in Q4 2025, $6.0 million in Q2 2025, and $6.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Zhengye Biotechnology Holding | 93.35 Mn | 86.03 Mn | - | 6.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.21 Mn |
| Jun 30, 2025 | 5.98 Mn |
| Dec 31, 2024 | 5.98 Mn |
| Dec 31, 2023 | 6.34 Mn |